Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato D Lopes

Showing results (41-50 of 731) with videos related to

Pageof 74
Sort By:
Thrombosis and Haemostasis|October 2, 2010
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsDavid A Garcia, Renato D Lopes, Elaine M Hylek
Postgraduate Medicine|July 3, 2013
Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012Adriano A Truffa, Renato D Lopes, L Kristin Newby
American Heart Journal|October 8, 2013
Responding to the letter to the editor by SaverRoberto Rocha Giraldez, Renato D Lopes, L Kristin Newby
Circulation|August 3, 2016
Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring"Paul L Hess, Renato D Lopes, Jeff S Healey
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs WarfarinAmit N Vora, John H Alexander, Renato D Lopes
JAMA|February 15, 2022
Diagnosis and Treatment of Acute Coronary Syndromes: A ReviewDeepak L Bhatt, Renato D Lopes, Robert A Harrington
JAMA Cardiology|December 5, 2019
Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-ReplyRalf E Harskamp, John H Alexander, Renato D Lopes
European Journal of Internal Medicine|April 10, 2024
When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trialsWilliam F McIntyre, Jeffrey S Healey, Renato D Lopes
European Journal of Internal Medicine|May 27, 2019
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUSRalf E Harskamp, John H Alexander, Renato D Lopes
JAMA Cardiology|November 11, 2023
Innovation in Event Adjudication-Human vs MachineKenneth W Mahaffey, C Michael Gibson, Renato D Lopes
Pageof 74

Showing results (41-50 of 731) with videos related to

Sort By:
Pageof 74
Thrombosis and Haemostasis|October 2, 2010
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsDavid A Garcia, Renato D Lopes, Elaine M Hylek
Postgraduate Medicine|July 3, 2013
Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012Adriano A Truffa, Renato D Lopes, L Kristin Newby
American Heart Journal|October 8, 2013
Responding to the letter to the editor by SaverRoberto Rocha Giraldez, Renato D Lopes, L Kristin Newby
Circulation|August 3, 2016
Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring"Paul L Hess, Renato D Lopes, Jeff S Healey
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs WarfarinAmit N Vora, John H Alexander, Renato D Lopes
JAMA|February 15, 2022
Diagnosis and Treatment of Acute Coronary Syndromes: A ReviewDeepak L Bhatt, Renato D Lopes, Robert A Harrington
JAMA Cardiology|December 5, 2019
Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-ReplyRalf E Harskamp, John H Alexander, Renato D Lopes
European Journal of Internal Medicine|April 10, 2024
When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trialsWilliam F McIntyre, Jeffrey S Healey, Renato D Lopes
European Journal of Internal Medicine|May 27, 2019
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUSRalf E Harskamp, John H Alexander, Renato D Lopes
JAMA Cardiology|November 11, 2023
Innovation in Event Adjudication-Human vs MachineKenneth W Mahaffey, C Michael Gibson, Renato D Lopes
Pageof 74